Danielle Helton Corwin
Danielle Helton Corwin is Global Regulatory Therapeutic Lead for Rare Disease/Rare Blood Disease, Sanofi.
ArticleFDA meetings: How to hold a successful meeting across the drug development lifecycle
This continuing professional development supplement discusses the available meeting options for products regulated by CDER and CBER, which should help the reader select the appropriate avenue to receive the Agency’s advice and develop a viable regulatory interactions strategy.
